EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation

Jingxuan Pan, Alfonso Quintás-Cardama, Hagop M. Kantarjian, Cem Akin, Taghi Manshouri, Peter Lamb, Jorge E. Cortes, Ayalew Tefferi, Francis J. Giles, Srdan Verstovsek*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds